Literature DB >> 27342807

Pleiotropic effects of ticagrelor: Myth or reality?

Omar Aït Mokhtar1, Mélanie Gaubert2, Marc Laine2, Laurent Bonello2, Regis Guieu2, Jennifer Cautela2, Michaël Peyrol2, Jeremie Barraud2, Franck Thuny2, Françoise Dignat-Georges2, Florence Sabatier2, Julien Fromonot2, Pascal Rossi2, Franck Paganelli3.   

Abstract

Keywords:  Acute coronary syndrome; Adenosine plasma; Adénosine plasmatique; Antiplatelet; Antogoniste des récepteurs P2Y(12); P2Y(12) adenosine diphosphate receptor blocker; Syndrome coronaire aigu; Traitement anti-agrégant plaquettaire

Mesh：

Substances：

Year:  2016        PMID： 27342807     DOI： 10.1016/j.acvd.2016.04.001

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN： 1875-2128            Impact factor:   2.340


× No keyword cloud information.
  4 in total

Review 1.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

2.  Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease.

Authors:  Matthieu Pelletier-Galarneau; Chad R R N Hunter; Kathryn J Ascah; Rob S B Beanlands; Girish Dwivedi; Robert A deKemp; Benjamin J W Chow; Terrence D Ruddy
Journal:  J Am Heart Assoc       Date:  2017-05-02       Impact factor: 5.501

3.  Infections Deaths in the PLATO Trial.

Authors:  Victor Serebruany; Jean-Francois Tanguay
Journal:  TH Open       Date:  2021-11-08

4.  Cardioprotective effect of extracellular vesicles derived from ticagrelor-pretreated cardiomyocyte on hyperglycemic cardiomyocytes through alleviation of oxidative and endoplasmic reticulum stress.

Authors:  Ceylan Verda Bitirim; Zeynep Busra Ozer; Dunya Aydos; Kardelen Genc; Seyma Demirsoy; Kamil Can Akcali; Belma Turan
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.